Optimizing GLP-1s for Women’s Health Conditions, Including PCOS to Address Hormonal Imbalances & Improve Metabolic Function Leading to Better Clinical Outcomes
- Addressing hormonal imbalances through targeted GLP-1 receptor agonism to regulate menstrual cycles and improve fertility in patients with polycystic ovary syndrome (PCOS)
- Improving insulin sensitivity in women with PCOS to enhance metabolic function, reducing the long-term risk of developing type 2 diabetes and cardiovascular disease
- Providing a holistic treatment option for women’s health to manage complex comorbidities in one therapy and improves overall well-being and quality of life